The proposed business combination will advance significant therapeutic discovery collaborations with some of the most prominent biopharma companies in the world, including Roche-Genentech, Sanofi, Bayer, and Merck KGaA. Moreover, there is the potential for approximately $200 million (£156 million) in milestone payments over the next 2 years from these current partnerships and there is the […]